Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark: an Open-Label, Pragmatic, Randomised Controlled Trial

NCT06295120 is registered in ClinicalTrials.gov with Research Unit for General Practice in Aalborg as lead sponsor.

NCT NCT06295120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06295120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark: an Open-Label, Pragmatic, Randomised Controlled Trial
Lead sponsor
Research Unit for General Practice in Aalborg
Phase
Phase 4
Overall status
Recruiting
Start date
November 13, 2023
Completion date
March 31, 2026
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired pneumonia